Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: A single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
Số trang: 10
Loại file: pdf
Dung lượng: 1.05 MB
Lượt xem: 6
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: A single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Gastro-oesophageal Checkpoint inhibition Metastatic disease include chemotherapy Systemic therapy Dysphagia recurrenceTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 175 0 0 -
6 trang 169 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 147 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 125 0 0 -
12 trang 98 0 0
-
19 trang 76 0 0
-
17 trang 68 0 0
-
9 trang 46 0 0
-
12 trang 40 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 39 0 0